PTX3 and stroke disorder: Significant increases in stroke patients versus controls were obtained for serum PTX3 (3.14 ± 1.23 vs. 2.44 ± 0.74 ng/ml; p < .001) and C‐reactive protein (CRP – 1.53 ± 0.38 vs. 1.35 ± 0.35 μg/ml; p < .05).